J0752 Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)

Short descriptor: Hiv prep, oral lenacapavir

✓ Active HCPCS Level II 2026
Open J0752 in the app →

Look up J0752 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J0752 is the HCPCS Level II code for Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Other carrier priced.

Classification & CMS Attributes

Medicare Coverage
Special coverage instructions apply (code D)
Part B Pricing
Other carrier priced (indicator 57)
Type of Service
Medical care
Effective Date
2025-10-01
2026 Maintenance
No change this year

Drug Details

Drug / Substance
lenacapavir, fda approved prescription, only for use as hiv pre-exposure prophylaxis
Dose / Unit
300 mg
Route
Oral

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J0752 with the canonical source and edition:

J0752 — Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv). ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J0752

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J0752

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial